Price change (24h):
1.98%
High (24h):
$24.74
Low (24h):
$24.25
Volume (24h):
$1.21K
Market Cap:
$271.04K
All Time High:
17.90% $29.54
Apr 20, 2026
All Time Low:
3% $23.61
Jun 25, 2026
0.00 %(1Y)
$24.25
Price change (24h):
1.98%
High (24h):
$24.74
Low (24h):
$24.25
Volume (24h):
$1.21K
Market Cap:
$271.04K
All Time High:
17.90% $29.54
Apr 20, 2026
All Time Low:
3% $23.61
Jun 25, 2026
Pfizer tokenized stock (xStock) (PFEX) is a cryptocurrency representing a fractional legal claim to Pfizer Inc. common equity, issued under the Backed Finance xStocks umbrella. The instrument belongs to the expanding class of Real World Assets (RWA), sitting squarely at the intersection of traditional equities and blockchain-based tokenization.
xStocks dismantle the entrenched friction of cross-border investing—brokerage accounts, intermediation chains, and jurisdictional gatekeeping. Each PFEX token mirrors the value of a single Pfizer share, held in custody by a regulated depository, and grants a direct beneficial claim enforceable under European Union securities law. The construction renders restricted US stock exposure instantly accessible to non-American users across both centralized and decentralized trading venues.
The token operates on the Solana network. Its codebase also lives natively on Ethereum, Arbitrum, Mantle, and The Open Network, sidestepping the liquidity fragmentation that plagues single-chain assets.
The asset’s smart contracts are instantiated across five distinct ledgers, each conforming to the host chain’s native token interface. This multi-settlement architecture allows the same logical unit of stock value to move within Solana’s high-throughput parallel runtime, Ethereum’s EVM environment, and TON’s sharded proof-of-stake chain, without relying on third-party bridge wrapping.
Backed Finance, a Swiss-based issuer, architected the xStocks framework to comply with the EU’s prospectus requirements for tokenized securities. The product line emerged from the conviction that equity markets could be opened programmatically, rather than through incremental regulatory harmonization. Early iterations focused on a basket of 57 US stocks and ETFs, positioning PFEX as a single-asset entry point.
The long-term design objective is to collapse the artificial wall between legacy stock exchanges and global decentralized finance. By encoding share ownership into a cryptographic token, PFEX removes settlement delays, custodian silos, and the geographic lockout that leaves vast pools of capital stranded outside US equity markets.
Mechanically, the token functions as a cryptographically authenticated evidence of ownership in a depository-held share. Transfers on-chain update the registry of beneficial interest without moving the underlying custody asset. In DeFi protocols, PFEX operates as a standardized collateral type—it plugs into lending markets, automated liquidity pools, and structured yield products, generating capital efficiency identical to any fungible token, yet backed by a legal claim on Pfizer stock dividends and corporate actions.
A DeFi protocol might accept PFEX as collateral to mint a stablecoin, enabling a user to lever exposure without a stockbroker. Market makers deposit the token into concentrated liquidity positions to earn swap fees, effectively underwriting the on-chain order book. An arbitrageur can buy PFEX below the official exchange-listed share price and redeem the underlying, assuming the authorized participant infrastructure permits, compressing the spread between the token and its equity reference.
Pfizer tokenized stock (xStock) has a total supply of 3,027,249.47 tokens. Currently, 13,576.58 are in circulation. With a market capitalization of $366,885.00, Pfizer tokenized stock (xStock) ranks #4,059 among all cryptocurrencies.
| Date | Open | Close | High | Low |
|---|---|---|---|---|
| 11/07/2026 | $24.25 | $24.25 | $24.25 | $24.25 |
| 10/07/2026 | $24.16 | $24.25 | $24.74 | $24.16 |
| 09/07/2026 | $24.22 | $24.16 | $24.22 | $24.09 |
| 08/07/2026 | $24.01 | $24.22 | $24.31 | $24.01 |
| 07/07/2026 | $23.79 | $24.01 | $24.04 | $23.79 |
| 06/07/2026 | $24.33 | $23.79 | $24.33 | $23.78 |
AI trades 24/7 automatically Catch every opportunity
Zero-emotion algorithm Disciplined strategy
Passive income Set & forget automation
20,000+
traders trusted Stoic AI
$200M+
in cumulative assets under management since inception
2015
year of company foundation
Disclaimer:
This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.
Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.